Ocuphire Pharma Inc. (OCUP)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY09	FY08	FY07	FY06	FY05
Revenue	19.05M	39.85M	589.00K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	190.61K
Cost of Revenue	6.00K	4.00K	4.00K	8.00K	3.00K	48.21K	42.36K	32.92K	27.50K	-	-	-	-	-	-	-	-	-
Gross Profit	19.04M	39.85M	585.00K	-8.00K	-3.00K	-48.21K	-42.36K	-32.92K	-27.50K	-	-	-	-	-	-	-	-	190.61K
Operating Income	-10.56M	18.23M	-22.70M	-19.97M	-4.19M	-20.54M	-17.35M	-16.41M	-18.26M	-13.27M	-7.98M	-6.58M	-16.13M	-6.47M	-5.15M	-4.43M	-6.72M	-
Interest Income	-	150.00K	2.00K	6.85M	313.70K	254.34K	207.00K	118.56K	103.27K	133.91K	49.28K	21.09K	109.24K	-67.44K	-260.53K	-128.12K	-331.25K	-
Pretax Income	-9.97M	18.20M	-56.69M	-24.62M	-6.17M	-14.37M	-25.29M	-9.31M	-14.38M	-18.52M	-9.50M	-6.23M	-11.34M	-6.39M	-4.91M	-4.30M	-6.49M	-6.35M
Net Income	-9.99M	17.89M	-56.53M	-31.48M	-7.51M	-14.37M	-25.29M	-9.31M	-14.38M	-18.52M	-9.50M	-6.23M	-11.34M	-6.39M	-4.91M	-4.30M	-6.49M	-6.35M
Selling & General & Admin	11.95M	7.27M	8.12M	2.82M	1.82M	7.38M	6.60M	6.29M	6.09M	6.25M	4.26M	2.71M	3.55M	2.94M	2.53M	2.73M	3.05M	2.56M
Research & Development	17.65M	14.36M	15.17M	6.65M	2.37M	13.11M	10.72M	10.09M	12.15M	7.02M	3.25M	3.39M	11.99M	3.25M	2.43M	1.53M	3.33M	1.52M
Other Expenses	1.84M	-14.00K	-157.00K	9.00K	-68.00K	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	29.61M	21.62M	23.29M	9.47M	4.19M	20.49M	17.31M	16.38M	18.24M	13.27M	7.51M	6.11M	15.54M	6.20M	4.96M	4.26M	6.38M	4.08M
Interest Expense	-	9.00K	2.00K	6.85M	1.41M	-	-	-	-	-	-	-	-	-	-	-	99.65K	-
Selling & Marketing Expenses	-6.00K	-	-	-	-	6.64M	-42.36K	-32.92K	-27.50K	-	-	-	-	-	-	-	-	-
Cost & Expenses	29.61M	21.62M	23.29M	9.47M	4.19M	20.54M	17.35M	16.41M	18.26M	13.27M	7.51M	6.11M	15.54M	6.20M	4.96M	4.26M	6.38M	4.08M
Income Tax	12.00K	315.00K	-159.00K	6.86M	1.34M	-161.14K	2.00	5.00	2.00	-	-	-	-	-	-	-	-	6.35M
Shares Outstanding (Basic)	21.59M	19.93M	14.85M	4.66M	711.21K	685.74K	570.63K	453.01K	379.98K	176.11M	128.65M	97.14M	93.05M	61.41M	55.86M	50.33M	48.87M	41.98M
Shares Outstanding (Diluted)	21.59M	20.60M	14.85M	4.66M	711.21K	685.74K	570.63K	453.01K	379.98K	176.11M	128.65M	97.14M	93.05M	61.41M	55.86M	50.33M	48.87M	41.98M
EPS (Basic)	-0.46	0.90	-3.81	-6.75	-10.56	-20.95	-44.33	-20.55	-37.86	-0.11	-0.07	-0.06	-0.12	-0.1	-0.09	-0.09	-0.13	-0.15
EPS (Diluted)	-0.46	0.87	-3.81	-6.75	-10.56	-20.95	-44.33	-20.55	-37.86	-0.11	-0.07	-0.06	-0.12	-0.1	-0.09	-0.09	-0.13	-0.15
EBITDA	-10.56M	18.21M	-22.86M	-9.45M	-4.26M	-20.49M	-17.31M	-16.38M	-18.24M	-13.27M	-7.94M	-6.54M	-16.09M	-6.42M	-5.10M	-4.37M	-6.59M	96.40K
Depreciation & Amortization	6.00K	4.00K	4.00K	8.00K	3.00K	48.21K	42.36K	32.92K	27.50K	-	37.13K	42.39K	45.07K	41.60K	55.74K	65.07K	124.51K	96.40K